{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T01:14:07Z","timestamp":1707873247654},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,13]]},"DOI":"10.7759\/cureus.54134","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T18:58:50Z","timestamp":1707850730000},"source":"Crossref","is-referenced-by-count":0,"title":["Daptomycin and Ceftaroline Combination Therapy in Complicated Endovascular Infections Caused by Methicillin-Resistant Staphylococcus epidermidis"],"prefix":"10.7759","author":[{"given":"S\u00edlvia","family":"Policarpo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Duro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno R","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lurdes","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/2049936119886504","article-title":"Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant Staphylococcus aureus bacteremia after monotherapy failure","volume":"6","author":"Hornak JP","year":"2019","unstructured":"Hornak JP, Anjum S, Reynoso D. Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant Staphylococcus aureus bacteremia after monotherapy failure. Ther Adv Infect Dis. 2019, 6:10.1177\/2049936119886504","journal-title":"Ther Adv Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02483-18","article-title":"Clinical data on daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"63","author":"Geriak M","year":"2019","unstructured":"Geriak M, Haddad F, Rizvi K, et al.. Clinical data on daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2019, 63:10.1128\/AAC.02483-18","journal-title":"Antimicrob Agents Chemother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz538","article-title":"Multicenter cohort of patients with methicillin-resistant Staphylococcus aureus bacteremia receiving daptomycin plus ceftaroline compared with other MRSA treatments","volume":"7","author":"McCreary EK","year":"2020","unstructured":"McCreary EK, Kullar R, Geriak M, et al.. Multicenter cohort of patients with methicillin-resistant Staphylococcus aureus bacteremia receiving daptomycin plus ceftaroline compared with other MRSA treatments. Open Forum Infect Dis. 2020, 7:10.1093\/ofid\/ofz538","journal-title":"Open Forum Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106310","article-title":"Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care","volume":"57","author":"Johnson TM","year":"2021","unstructured":"Johnson TM, Molina KC, Miller MA, Kiser TH, Huang M, Mueller SW. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care. Int J Antimicrob Agents. 2021, 57:10.1016\/j.ijantimicag.2021.106310","journal-title":"Int J Antimicrob Agents"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.15.98","article-title":"Staphylococcus epidermidis as a cause of bacteremia","volume":"10","author":"Kleinschmidt S","year":"2015","unstructured":"Kleinschmidt S, Huygens F, Faoagali J, Rathnayake IU, Hafner LM. Staphylococcus epidermidis as a cause of bacteremia. Future Microbiol. 2015, 10:1859-79. 10.2217\/fmb.15.98","journal-title":"Future Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2016.94","article-title":"Biofilms: an emergent form of bacterial life","volume":"14","author":"Flemming HC","year":"2016","unstructured":"Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol. 2016, 14:563-75. 10.1038\/nrmicro.2016.94","journal-title":"Nat Rev Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1086\/320184","article-title":"Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999","volume":"32 Suppl 2","author":"Diekema DJ","year":"2001","unstructured":"Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001, 32 Suppl 2:S114-32. 10.1086\/320184","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.10.2231","article-title":"Antimicrobial susceptibility of coagulase-negative staphylococci","volume":"38","author":"Archer GL","year":"1994","unstructured":"Archer GL, Climo MW. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother. 1994, 38:2231-7. 10.1128\/AAC.38.10.2231","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2007.03.004","article-title":"Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey","volume":"164","author":"Koksal F","year":"2009","unstructured":"Koksal F, Yasar H, Samasti M. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey. Microbiol Res. 2009, 164:404-10. 10.1016\/j.micres.2007.03.004","journal-title":"Microbiol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2017.0309","article-title":"Coagulase-negative Staphylococci isolated from human bloodstream infections showed multidrug resistance profile","volume":"24","author":"Pedroso SH","year":"2018","unstructured":"Pedroso SH, Sandes SH, Filho RA, et al.. Coagulase-negative Staphylococci isolated from human bloodstream infections showed multidrug resistance profile. Microb Drug Resist. 2018, 24:635-47. 10.1089\/mdr.2017.0309","journal-title":"Microb Drug Resist"},{"key":"ref11","article-title":"Coagulase negative staphylococci - a fast emerging threat","volume":"65","author":"Latif M","year":"2015","unstructured":"Latif M, Usman J, Gilani M, et al.. Coagulase negative staphylococci - a fast emerging threat. J Pak Med Assoc. 2015, 65:283-6.","journal-title":"J Pak Med Assoc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(90)90481-6","article-title":"Sequence comparison of mecA genes isolated from methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis","volume":"94","author":"Ryffel C","year":"1990","unstructured":"Ryffel C, Tesch W, Birch-Machin I, et al.. Sequence comparison of mecA genes isolated from methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Gene. 1990, 94:137-8. 10.1016\/0378-1119(90)90481-6","journal-title":"Gene"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2011.617777","article-title":"Coagulase-negative Staphylococcus bacteraemia accounts for one third of Staphylococcus bacteraemia in a French university hospital","volume":"44","author":"N'Guyen Y","year":"2012","unstructured":"N'Guyen Y, Baumard S, Vernet-Garnier V, Batalla AS, de Champs C, Jaussaud R, Strady C. Coagulase-negative Staphylococcus bacteraemia accounts for one third of Staphylococcus bacteraemia in a French university hospital. Scand J Infect Dis. 2012, 44:79-85. 10.3109\/00365548.2011.617777","journal-title":"Scand J Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaa114","article-title":"Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK","volume":"3","author":"Brown NM","year":"2021","unstructured":"Brown NM, Goodman AL, Horner C, Jenkins A, Brown EM. Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK. JAC Antimicrob Resist. 2021, 3:10.1093\/jacamr\/dlaa114","journal-title":"JAC Antimicrob Resist"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu C","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, et al.. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011, 52:e18-55. 10.1093\/cid\/ciq146","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)","volume":"36","author":"Habib G","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ, et al.. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015, 36:3075-128. 10.1093\/eurheartj\/ehv319","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler VG Jr","year":"2006","unstructured":"Fowler VG Jr, Boucher HW, Corey GR, et al.. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006, 355:653-65. 10.1056\/NEJMoa053783","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.07.011","article-title":"Daptomycin in the treatment of patients with infective endocarditis: experience from a registry","volume":"120","author":"Levine DP","year":"2007","unstructured":"Levine DP, Lamp KC. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry. Am J Med. 2007, 120:S28-33. 10.1016\/j.amjmed.2007.07.011","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01563-13","article-title":"High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis","volume":"57","author":"Carugati M","year":"2013","unstructured":"Carugati M, Bayer AS, Mir\u00f3 JM, et al.. High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis. Antimicrob Agents Chemother. 2013, 57:6213-22. 10.1128\/AAC.01563-13","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2219","article-title":"Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial","volume":"350","author":"Paul M","year":"2015","unstructured":"Paul M, Bishara J, Yahav D, et al.. Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial. BMJ. 2015, 350:h2219. 10.1136\/bmj.h2219","journal-title":"BMJ"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.08.007","article-title":"Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia","volume":"65","author":"Park HJ","year":"2012","unstructured":"Park HJ, Kim SH, Kim MJ, et al.. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia. J Infect. 2012, 65:505-12. 10.1016\/j.jinf.2012.08.007","journal-title":"J Infect"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1086\/600295","article-title":"Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem","volume":"49","author":"Jang HC","year":"2009","unstructured":"Jang HC, Kim SH, Kim KH, et al.. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis. 2009, 49:395-401. 10.1086\/600295","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/224276-daptomycin-and-ceftaroline-combination-therapy-in-complicated-endovascular-infections-caused-by-methicillin-resistant-staphylococcus-epidermidis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T18:58:52Z","timestamp":1707850732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/224276-daptomycin-and-ceftaroline-combination-therapy-in-complicated-endovascular-infections-caused-by-methicillin-resistant-staphylococcus-epidermidis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.54134","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,13]]}}}